Graça M. Dores
0000-0002-3985-2935
Publication & Citation Trends
Publications
0 total
Abstract B126: Cardiovascular disease mortality among multiple myeloma patients treated with chemoimmunotherapy, 2000-2021
Cited by 0
Semantic Scholar
Postmarket review of photosensitivity associated with select BRAF and MEK inhibitors.
Cited by 0
Semantic Scholar
Postmarketing Cases of Erdafitinib‐Associated Skeletal Growth Toxicity Events in Pediatric Patients
Cited by 0
Semantic Scholar
Temporal patterns in US population‐based patient survival among adults treated with chemotherapy and/or immunotherapy for multiple myeloma, 2000–2020
Cited by 0
Semantic Scholar
Dasatinib-Associated Chylothorax: A Review of Cases Reported to the FDA Adverse Event Reporting System and the Published Literature
Cited by 0
Semantic Scholar
Survival of adult AML patients treated with chemotherapy in the U.S. population by age, race and ethnicity, sex, calendar-year period, and AML subgroup, 2001–2019 OA
Cited by 22
Semantic Scholar
Patterns of platelet use evaluated in EHR networks of the Biologics Effectiveness and Safety Initiative, 2012–2018
Cited by 0
Semantic Scholar
Hepatic veno-occlusive disease with asparaginase products: a review of cases reported to the FDA adverse event reporting system and published in the literature
Cited by 3
Semantic Scholar
T-Cell Neoplasms after B-Cell Neoplasms – The pre-CAR-T Era OA
Cited by 6
Semantic Scholar
Research Topics
Lymphoma Diagnosis and Treatment
(29)
Multiple and Secondary Primary Cancers
(19)
Acute Myeloid Leukemia Research
(16)
Chronic Lymphocytic Leukemia Research
(13)
Acute Lymphoblastic Leukemia research
(12)
Affiliations
University of Iowa
United States Department of Health and Human Services
National Institutes of Health
Center for Biologics Evaluation and Research
United States Food and Drug Administration